Clinical Trials
KalVista begins phase 1 study of KVD818 in hereditary angioedema
KalVista Pharmaceuticals announced the dosing of the first subject in a first-in-human clinical trial to evaluate the safety, pharmacokinetics and pharmacodynamics of orally delivered...
Clinical Trials
Alzheimer’s drug shows promise for patients in phase III trial
At the Alzheimer's Association International Conference 2016 (AAIC 2016), held in Toronto, Canada, researchers reveal how a drug called LMTX shows promise for halting...
Packaging & Labelling
Nelipak Corp. expands into Puerto Rico thanks to acquisition
Nelipak Corp. has acquired thermoforming company Tegrant Alloyd Brands of Puerto Rico Inc. (TABPR), a subsidiary of Sonoco Products Co. Located in Juncos, the...
Production & Manufacturing
Agilent Chooses Colorado for New Pharma Manufacturing Facility
Agilent Technologies reports that it acquired 20 acres in Weld County in northern Colorado, on which it plans to build a pharmaceutical manufacturing facility....
News
Eisai And Mamorio To Jointly Develop “Me-Mamorio” Tracking Tool To Support People With Dementia Going Out
Eisai Co., Ltd and MAMORIO, Inc announced that they have entered into an agreement to collaborate on the development of the Me-MAMORIO1 tracking tool...
Packaging & Labelling
Alcami Announces New Highly Potent API Capabilities and Capacity in Germantown, WI
Alcami, a leading provider of custom development and manufacturing services for the pharmaceutical and biotechnology industries, today announces its plans to expand capabilities for...
Press Releases
AstraZeneca provides update on Phase III trial of Selumetinib in non-small cell lung cancer
AstraZeneca announced results from the Phase III SELECT-1 trial of the MEK 1/2 inhibitor, selumetinib, in combination with docetaxel chemotherapy as 2nd-line treatment...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read